Your session is about to expire
← Back to Search
e-CBT vs Mental Health Coaching for Anxiety
N/A
Waitlist Available
Led By Nazanin Alavi, MD, FRCPC
Research Sponsored by Dr. Nazanin Alavi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 6, week 12, 6-month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the efficacy of an electronically-delivered cognitive behavioural therapy (e-CBT) program to a mental health coaching program to treat generalized anxiety disorder (GAD).
Who is the study for?
This trial is for adults aged 18-65 with Generalized Anxiety Disorder (GAD) as per DSM-5, who can understand English and have reliable internet access. It's not suitable for those with active psychosis, severe substance abuse, suicidal thoughts, ongoing psychotherapy or acute mania.
What is being tested?
The study compares an online cognitive behavioural therapy program (e-CBT) to a mental health coaching program in treating GAD. Over 12 weeks, participants will either engage in e-CBT modules with therapist feedback or weekly themed chats through the platform.
What are the potential side effects?
While there are no direct side effects from participating in e-CBT or mental health coaching programs themselves, discussing anxiety might temporarily increase distress or emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 0, week 6, week 12, 6-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 6, week 12, 6-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in symptoms (Depression Anxiety Scale - 42 Item)
Change in symptoms (Generalized Anxiety Disorder - 7 Item)
Change in symptoms (Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: e-CBTExperimental Treatment1 Intervention
12 weekly sessions of approximately 30 slides and interactive content, delivered through OPTT. The e-CBT module content mirrors in-person standard CBT content, including different weekly topics, general information, skill overviews, and homework. Participants are instructed to go through the content and complete homework at the end of the session which helps them practice skills they learned through that session. Homework is submitted through OPTT and reviewed by the therapist assigned to the participant, who will provide personalized feedback within three days of submission. Therapists have access to pre-designed session-specific feedback templates to use as a basic structure to write their feedback. By doing so, the time needed to respond to each patient is reduced and therefore the number of patients each therapist can handle increases.
Group II: Mental Health CoachingExperimental Treatment1 Intervention
Weekly interactions with the therapist using general questions on the following topics:
Week 1 (Mood) Week 2 (Sleep) Week 3 (Activity) Week 4 (Hobbies) Week 5 (Friendship) Week 6 (New Events) Week 7 (Job/Study) Week 8 (Diet/Food) Week 9 (Books/Movies/Shows) Week 10 (Phone/Apps/Games) Week 11 (Habits) Week 12 (Accomplishments)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-CBT
2021
N/A
~300
Mental Health Coaching
2021
N/A
~100
Find a Location
Who is running the clinical trial?
Dr. Nazanin AlaviLead Sponsor
12 Previous Clinical Trials
1,026 Total Patients Enrolled
1 Trials studying Anxiety
60 Patients Enrolled for Anxiety
Queen's UniversityLead Sponsor
372 Previous Clinical Trials
123,911 Total Patients Enrolled
5 Trials studying Anxiety
500 Patients Enrolled for Anxiety
Nazanin Alavi, MD, FRCPCPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
79 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger